PUBLICATIONS

Selected Publications

iSTAND trial of IVIG in POTS: a step in the right direction, but more studies are needed

Elevated total serum IgM predicts the presence of antiphospholipid antibodies in dysautonomia patients

What you need to know about migraine in Hughes syndrome patients

Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS)

Postural Tachycardia Syndrome (POTS) and other Autonomic Disorders in Antiphospholipid (Hughes) Syndrome

A Trial of Antithrombotic Therapy in Patients with Refractory Migraine and Antiphospholipid Antibodies: A retrospective study of 75 patients

Diagnosis of Mast Cell Activation Syndrome: A global “consensus-2”

Autoimmunity, Autonomic Neuropathy, and the HPV Vaccination: A Vulnerable Subpopulation

Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On

Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 patients

How we treat Autoimmune Small Fiber Polyneuropathy with Immunoglobulin Therapy

Excipient Reactivity in Patients with Mast Cell Activation Syndrome - In Press

Deep Capillary Retinal Ischemia and High-Titer Prothrombin-Associated Antiphospholipid Antibodies: A case series of three patients

Autonomic Neuropathy—in its many guises—as the Initial Manifestation of the Antiphospholipid Syndrome

Dosing considerations in the use of the Direct Oral Anticoagulants in the Antiphospholipid Syndrome

Case 9-2014: A woman with increasing dyspnea

Center for Multisystem Disease

Conditions We Treat